The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection

References

• Hussein K, Rabino G, Feder O., et al. Risk factors for meningitis in neurosurgical patients with cerebrospinal fluid drains: prospective observational cohort study. Acta Neurochir. 2019;161(3):517–524. doi:10.1007/s00701-019-03801-y
   PubMed Web of Science ®Google Scholar
• Long W, Yuan J, Liu J, et al. Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: a Case Report and Review of Literature. Front Neurol. 2018;9:518. doi:10.3389/fneur.2018.00518
   Web of Science ®Google Scholar
• Kurdyumova NV, Danilov GV, Ershova ON. Features of Nosocomial Meningitis in Patients of a Neurosurgical Critical Care Unit. Zh Vopr Neirokhir Im N N Burdenko. 2015;79:55–59. doi:10.17116/neiro201579347-51
   Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Cook AM, Robert KDM, Owen RD, Pesaturo AB, Hatton J. Intracerebroventricular Administration of Drugs. Pharmacotherapy. 2009;29:832–845. doi:10.1592/phco.29.7.832
   PubMed Web of Science ®Google Scholar
• Tsuji BT, Pogue JM, Zavascki AP, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39:10–39. doi:10.1002/phar.2209
   PubMed Web of Science ®Google Scholar
• Lauretti L, D’Alessandris QG, Fantoni M, et al. First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii. J Neurosurg. 2017;127(2):370–373. doi:10.3171/2016.6.JNS16352
   PubMed Web of Science ®Google Scholar
• Deng ZW. A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection. Medicine. 2019;98:e15139. doi:10.1097/MD.0000000000015139
   Web of Science ®Google Scholar
• Li W, Li -D-D, Yin B, et al. Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: a case report. World J Clin Cases. 2021;9:651–658. doi:10.12998/wjcc.v9.i3.651
   Web of Science ®Google Scholar
• Cook AM, Robert KDM, Owen RD, Pesaturo AB, Hatton J. Pesaturo, Jimmi Hatton. Intracerebroventricular administration of drugs. Pharmacotherapy. 2009;29:832–845. doi:10.1592/phco.29.7.832
   PubMed Web of Science ®Google Scholar
• Xing H, Cheng C, Zhang Y, et al. Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: a Case Report. Front Pediatr. 2021;9:564991. doi:10.3389/fped.2021.564991
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen K, Zhao J, Wang Q, Zhou J. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report. J Chemother. 2018;30:49–52. doi:10.1080/1120009X.2017.1338846
   PubMed Web of Science ®Google Scholar
• Romney Humphries AMB, Hindler JA, Schuetzd AN. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100. J Clin Microbiol. 2021;59:13–21.
   Web of Science ®Google Scholar
• EUCAST. Breakpoint tables for interpretation of MICs and zone diameters Version 12.0[EB/OL];2020. Available from: https://www.eucast.org/. Accessed August 17, 2022.
   Google Scholar
• Chen J, Tang M, Liu M, et al. Neferine and lianzixin extracts have protective effects on undifferentiated caffeine-damaged PC12 cells. BMC Complement Med Ther. 2020;20(1):76. doi:10.1186/s12906-020-2872-2
   Google Scholar
• Tamma PD. Infectious Diseases Society of America Guidance on the Treatment of AmpC beta-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections. Clin Infect Dis. 2021. doi:10.1093/cid/ciab1013
   Web of Science ®Google Scholar
• Paul M. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2021. doi:10.1016/j.cmi.2021.11.025
   Web of Science ®Google Scholar
• Petersen PJ, Labthavikul P, Jones CH, Bradford PA. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother. 2006;57(3):573–576. doi:10.1093/jac/dki477
   PubMed Web of Science ®Google Scholar
• Sopirala MM, Mangino JE, Gebreyes WA, et al. Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2010;54:4678–4683. doi:10.1128/AAC.00497-10
   PubMed Web of Science ®Google Scholar
• Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis. 2005;52(3):203–208. doi:10.1016/j.diagmicrobio.2005.05.002
   PubMed Web of Science ®Google Scholar
• Waites KB, Duffy LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother. 2006;50(10):3479–3484. doi:10.1128/AAC.00210-06
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017;64(6):e34–e65. doi:10.1093/cid/ciw861
   PubMed Web of Science ®Google Scholar
• Annabi E, Ben salem I, Abid-Essefi S. Acetamiprid, a neonicotinoid insecticide, induced cytotoxicity and genotoxicity in PC12 cells. Toxicol Mech Methods. 2019;29(8):580–586. doi:10.1080/15376516.2019.1624907
   PubMed Web of Science ®Google Scholar